Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Angie K Hernandez"'
Autor:
An Dinh, Jose M. Munita, Lina V Millan, Cesar A. Arias, Paola Cubides, Lina P Carvajal, Rafael Rios, Carlos Seas, Maritza Berrio, Lorena Diaz, Betsy Esperanza Castro, Erika Forero, Jinnethe Reyes, Angie K Hernandez, Monica L Vargas, Sandra Rincon
Publikováno v:
Repositorio U. El Bosque
Universidad El Bosque
instacron:Universidad El Bosque
J Antimicrob Chemother
Universidad El Bosque
instacron:Universidad El Bosque
J Antimicrob Chemother
BackgroundVancomycin is a common first-line option for MRSA infections. The heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA) phenotype is associated with therapeutic failure. However, hVISA isolates are usually reported as vancomyc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f1cc15812b080cb97574d9202d1f1404
https://doi.org/10.1093/jac/dkaa221
https://doi.org/10.1093/jac/dkaa221
Autor:
Oscar Ortega-Recalde, Angie K Hernandez, William C Shropshire, Lorena Diaz, Sandra Rincon, Cesar A. Arias, Lina P Carvajal, Rafael Rios, Catalina Espitia-Acero, Sebastian Solano-Gutierrez, Aura M Echeverri, Jinnethe Reyes
Publikováno v:
Open Forum Infectious Diseases
Background Latin-American (LA) countries are among the largest mercury (Hg) polluters in the world. Fittingly, a significant high frequency (>50%) of Hg resistance genes (MRG) has been observed in LA MRSA genomes, including USA300-LV clone, which con
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::50f5361893734519e4e0d6931a508936
https://doi.org/10.1093/ofid/ofaa439.1623
https://doi.org/10.1093/ofid/ofaa439.1623
Autor:
Monica Liliana Vargas Ardila, Angie K Hernandez, Betsy Castro-Cardozo, Rafael Rios, Jose M. Munita, Lorena Diaz, Cesar A. Arias, Jinnethe Reyes, Carlos Seas, Lina P Carvajal, Lina V Millan
Publikováno v:
Open Forum Infectious Diseases
Background Vancomycin (VAN) is a first-line therapeutic option for severe MRSA infections, especially in Latin America where other options are limited. However, reduced susceptibility to VAN may lead to therapeutic failures. The molecular mechanisms
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aca4b65caf8ff8223334f3bb165cc697
https://doi.org/10.1093/ofid/ofz359.089
https://doi.org/10.1093/ofid/ofz359.089
Autor:
Henry F. Chambers, Blake Hanson, Aura M Echeverri, Rafael Rios, Karen M Ordonez Diaz, Sandra Valderrama, Laura J. Rojas, Vance G. Fowler, Beatriz Ariza, Lina V Millan, Edilberto Cristancho Quintero, Soraya Salcedo, David van Duin, Gloria Cortes, Adriana Marin, Cesar A. Arias, Jinnethe Reyes, Lina P Carvajal, Angie K Hernandez, Lorena Diaz, Robert A. Bonomo, Barry N. Kreiswirth, Maria Virginia Villegas, Laura Mora, Sandra Vargas
Publikováno v:
Open Forum Infectious Diseases
Background Carbapenem-resistant Enterobacteriaceae (CRE) is a serious public health threat. A major epidemic of carbapenemase-producing Klebsiella pneumoniae has occurred in Colombia through complex mechanisms of blaKPC dissemination. In the framewor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb5bc666fddee9645ad6edc6e6408389
http://europepmc.org/articles/PMC6811030
http://europepmc.org/articles/PMC6811030